The polymerase chain reaction was used to measure the DNA copy number of human immunodeficiency virus (HIV). Differences in polymerase chain reaction amplification efficiency were controlled by amplifying known amounts of HIV DNA in parallel with samples. This technique is a sensitive, accurate, and reproducible method for the quantitation of HIV DNA.
Human immunodeficiency virus (HIV) causes acquired immune deficiency syndrome (AIDS) (2, 5). Sensitive and quantitative assays that directly measure HIV are urgently needed to monitor the progression of disease and to assess antiviral therapy. The polymerase chain reaction (PCR) assay (11) has been used to specifically amplify HIV DNA sequences (7, 12) . The amplified sequences can be increased 106-fold or more (14) and specifically detected by nucleic acid hybridization (7, 11, 12) . This method is extremely sensitive and capable of detecting very low levels of latent HIV in infected individuals (6, 8) .
Quantitation by the PCR assay uses the measurement of the relatively large amount of final product to deduce the amount of target present in the initial sample. The equation relating input and output amounts of DNA following amplification is Y = S x (1 + e)', where Y is the amount of DNA after amplification, S is the starting number of target copies, n is the number of cycles performed, and e is the efficiency of the reaction. The value of e can range from zero (no amplification of the target sequence) to one (exact doubling of the target sequence). This variation in efficiency has been a major obstacle in making the PCR assay a quantitative one (1) because the assay is sensitive to reaction conditions and the amount of target material being amplified. It is necessary, therefore, to compare each PCR measurement with a known standard that has similarly been amplified by PCR.
Two approaches to this standardization include the use of internal standards, which involve a eucaryotic gene amplified in the same tube as the target, and external standards, which involve known amounts of the target amplified in different tubes. Internal PCR standards have several disadvantages for the quantitation of HIV DNA, the most serious of which is that when HIV DNA and the internal standard are present in different amounts, they have different amplification efficiencies. In this study we developed a quantitative method to determine HIV DNA copy number with an external standard of known amounts of HIV amplified along with each sample to correct for the difference in the efficiency of amplification based on starting copy number.
( (9) . The DNA concentration of the plasmid was determined with a spectrophotometer.
Oligonucleotides SK01, SK02, SK29, SK30, SK38, SK39, SK68, and SK69 (7, 12) were synthesized. Oligonucleotide probes SK03, SK31, SK19, and SK70 were labeled with 32P by using polynucleotide kinase (New England BioLabs, Inc., Beverly, Mass.) (3).
The LAV strain of HIV type 1 (10) was grown in CEM cells, and growth was monitored by reverse transcriptase (13) and antigen production (E. I. du Pont de Nemours & Co., Inc., North Billerica, Mass.).
Isolation of cells and preparation of DNA. Infected and uninfected CEM cells were lysed with 0.5% sodium dodecyl sulfate (SDS), treated with proteinase K (IBI, New Haven, Conn.), phenol extracted, and ethanol precipitated. Nucleic acid was suspended in lx TE (10 mM Tris chloride, 1 mM EDTA [pH 8.0]), treated with RNase (Sigma Chemical Co., St. Louis, Mo.), phenol extracted, ethanol precipitated, and resuspended in 1x TE. The number of copies of HIV provirus present in a microgram of infected CEM cell DNA was determined by comparison with pBH10 on dot blots with 32P-labeled SK19 and SK70 (12) . DNA was extracted from peripheral blood mononuclear cells (PBMC) of AIDS patients and negative controls by the following protocol. Ten to 15 ml of blood was collected by vein puncture into EDTA-containing tubes. The PBMC were separated on a Lymphoprep gradient, washed once with phosphate-buffered saline, lysed with 400 jxl of sterile double-distilled water, and autoclaved for 20 min, followed by a slow exhaust. Samples were centrifuged in an Eppendorf centrifuge at full speed for 2 min, and the supernatants were transferred to new tubes. Samples were equilibrated to lx TE with lOx TE, treated with RNase for 1 h at 37°C, and treated with proteinase K for 1 h at 55°C. Following phenol extraction and ethanol precipitation, samples were sus-VOL. 28, 1990 pended in 100 pul of double-distilled water and the DNA concentration of the samples was determined with a spectrophotometer.
Amplification protocol. The PCR mixture contained lx PCR buffer (The Perkin-Elmer Cetus Corp., Norwalk, Conn.); 0.2 mM each dATP, dGTP, dCTP, and dTTP (Pharmacia, Inc., Piscataway, N.J.); 50 pmol of each primer pair (SK01-SK02, SK29-SK30, SK38-SK39, and SK68-SK69); and 2.5 U of Taq polymerase (Perkin-Elmer Cetus) (4). The final volume of each sample was 50 ,il.
One microgram of DNA from each patient and negative control was run for 30 cycles in accordance with the program listed below. Tenfold dilutions ranging from 106 to 101 copies of HIV provirus from LAV-infected CEM cells were amplified along with the patient samples. All samples were adjusted with lambda DNA (New England BioLabs) to a final DNA concentration of 1 ,ug per sample.
A DNA thermal cycler (Perkin-Elmer Cetus) was used to cycle the temperature of the samples. Samples were denatured for 3 min at 100°C and quickly cooled. Taq polymerase (Perkin-Elmer Cetus) was added, and 50 ,ul of mineral oil was laid over each sample. Each cycle was as follows: 94°C for 1 min, 55°C for 1 min, and 72°C for 1.5 min. After 30 cycles, samples were incubated at 72°C for 10 min and stored at 4°C until blotted.
Hybridization and construction of standard curves. Dot blots were made with 20 to 25 ,ul of each amplified sample. Blots were prehybridized at 37 or 50°C in a solution containing 3x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 0.01 M EDTA, 5x Denhardt solution, 100 ,ug of denatured salmon sperm DNA per ml, and 6% SDS. y_32p_ labeled probes were added to the prehybridization mixture to a final concentration of 106 cpm/ml, and blots were hybridized overnight at 37 or 50°C. Blots were washed at the hybridization temperature three times; the first wash was done with 2x SSC-0.1% SDS, the second wash was done with lx SSC-0.1% SDS, and the third wash was done with 0.5x SSC-0.1% SDS. Each wash lasted 30 min.
The blots were exposed to autoradiography film (Eastman Kodak Co., Rochester, N.Y.) for 2 h or overnight at -70°C. Following dot blotting, hybridization, and autoradiography, individual dots were cut out and placed in a scintillation cocktail (Ready Safe; Beckman Instruments, Inc., Fullerton, Calif.). The counts per minute were determined in a scintillation counter set for 32p. Each datum point was determined in duplicate. The counts per minute of samples were always greater than 200.
A standard curve was constructed from the counts obtained from the amplification of a known number of copies of HIV provirus. The counts per minute of patient samples minus the background counts were compared with the curve, permitting calculation of the number of copies of HIV provirus present in the original sample.
Sensitivity and reproducibility of the PCR assay. Amplification for 30 cycles followed by hybridization at 37°C allowed the detection of as few as five copies of pBH10 DNA. Well-to-well differences within the DNA thermal cycler were examined by amplifying samples containing a constant amount of HIV DNA in different wells. Amplification of 42 samples followed by hybridization and scintillation counting showed that the well-to-well differences had a coefficient of variation of 14%. This error also includes the error in the production of the dot blots and the counting of the individual dots. We did not use the 6 positions furthest from the temperature sensors (column 8) on our machine because these positions gave a much higher variation than Determination of PCR efficiency. The efficiency of amplifying HIV DNA with primer pairs SK38-SK39 and SK68-SK69 was determined with both LAV-infected CEM cell DNA and pBH10 DNA. A known number of copies were amplified for 30 cycles in accordance with the above-described protocol. After amplification, 25 ,ul of each sample was dot blotted along with standards of pBH10 DNA corresponding to the amount of product that would have been generated by amplification efficiencies of 100, 90, 80, 70, 60, and 50%. Following hybridization with y-32P-labeled SK19 or SK70, individual dots were cut out and counted. Efficiency curves were constructed to determine the efficiency of amplification. Figure 1 shows the efficiency of amplification with primer pairs SK38-SK39 and SK68-SK69 for 101 to 106 copies of HIV provirus in 1 ktg of total DNA. The efficiency of the reaction decreased with increasing amount of target for both primer pairs. This dependence of the amplification efficiency on the starting amount of target necessitated the use of external standards.
The efficiency of the amplification of HIV provirus was compared with the efficiency of the amplification of plasmid pBH10. Figure 2 shows that the efficiencies of amplifying equal numbers of copies of pBH10 DNA or LAV-infected CEM cell DNA were virtually the same, demonstrating that the results for infected cells can be directly related to copy number.
Accuracy of quantitation by PCR. To determine the accuracy of quantitating the initial copy numbers by PCR, we generated a standard curve by amplification of serial dilutions of pBH10 followed by dot blot hybridization and scintillation counting. Fig. 3 .
Determination of HIV copy number in DNA from PBMC of AIDS patients. Figure 4 shows Samples from one patient were quantitated 10 times, and the error based on the mean and standard deviation was calculated. The 14% coefficient of variation found in these samples was consistent with the result of the experiment in which well-to-well differences were examined. We conclude that the use of external standards and PCR amplification is a sensitive, accurate, and reproducible method for the quantitation of HIV. 
